|
Office of AIDS Research Advisory Council (OARAC)
|
Committee, Work group, Advisory group, or Task Force
|
CDC
|
OD/DPCPSI/OAR, NIAID
|
The Office of AIDS Research Advisory Council provides advice to the Director of the Office of AIDS Research (OAR) on the planning, coordination, and evaluation of research and other activities in respect to AIDS conducted or supported by the NIH. OARAC also advises the Secretary of Health and Human Services and the Director of NIH, on AIDS research programs, the development and annual review of the comprehensive plan for the conduct and support of all HIV/AIDS activities of the agencies of NIH, including research policies and priorities, and the coordination of domestic and international NIH AIDS efforts.
|
|
Office of Science and Technology Mo99 Stakeholders Working Group
|
Committee, Work group, Advisory group, or Task Force
|
CMS, FDA, OSG
|
NIBIB, NCI
|
The purpose of this working group is to oordinate the efforts of multiple stakeholders (Department of State, Department of Energy, Department of Homeland Security, Department of Health and Human Services, private sector) to establish a stable, long-term domestic supply of Mo99 (molybdenum-99) for medical purposes. Such a supply needs to be consistent with current international goals (to which the US is an active participant) of reduction in the use of high-enriched uranium in all reactors, including Mo99 production facilities, as well as full cost recovery solutions.
|
|
Opioid Use in Pregnancy and Neonatal Abstinence Syndrome
|
Meeting/ Workshop
|
CDC, FDA, SAMHSA
|
NICHD, NIDA, NINDS
|
This workshop will be of high impact in addressing critical gaps in research, including (1) Screening for opioid use in pregnancy (2) Complications of pregnancy associated with opioid use (3) Most appropriate treatment of pregnant women with opioid use disorders given risks and benefits (4) Treatment and management of infants with neonatal abstinence syndrome; and (5) long-term effects of prenatal opioid exposure on children and the role of preventive interventions to improve childhood outcomes for this high risk population.
|
|
Oral Health, Cancer Care, and You
|
Public Education Campaign
|
CDC
|
NIDCR, NCI, NINR
|
A series of publications to inform health care providers and patients about steps they can take to reduce the risk and impact of oral complications of cancer treatment.
|
|
OS PCORTF Leadership Council
|
Committee, Work group, Advisory group, or Task Force
|
AHRQ, CDC, CMS, FDA, HRSA, OS
|
OD/OSP, NCCIH, OD/DPCPSI/ODP, OD/OER
|
The Patient Protection and Affordable Care Act of 2010 created the Patient-Centered Outcomes Research Trust Fund (PCORTF) to help build the national capacity and infrastructure needed to conduct patient-centered outcomes research (PCOR), and to enable PCOR findings to be integrated into clinical practice. The Office of the Secretary (OS) of the U.S. Department of Health and Human Services (HHS) receives 4% of the PCORTF to build data capacity for PCOR. ASPE convenes a Leadership Council of HHS principals or their designees to develop a strategy for use of these funds and to determine yearly investments
|
|
Osteoporosis and Related Bone Diseases—National Resource Center
|
Resource Development
|
OS
|
NIAMS, NIA, NICHD, NIDCR, NIDDK, OD/DPCPSI/ORWH
|
Provides patients, health professionals and the public with an important link to resources and information on metabolic bone diseases, including osteoporosis, Paget’s disease of the bone and osteogenesis imperfecta.
|
|
OSTP Interagency Working Group on Medical Imaging
|
Committee, Work group, Advisory group, or Task Force
|
CMS, FDA
|
NIBIB, NCI, NIAMS, NICHD, NIDDK
|
The IWMI is co-chaired by NIH and NIST and is working to identify gaps and develop a roadmap to accelerate technology development that is more effective, improves patient care, and has the potential to lower cost. The working group, which includes twelve federal agencies, has determined key strategic directions through a series of stakeholder meetings. Areas identified as important for joint focus include deep/machine learning, quantitative and high-value imaging, and inter-agency collaboration to accelerate translation.
|
|
P63, P13K and RAS oncogenes in tumorigenesis, immune deregulation and therapy of squamous cell carcinoma
|
Research Initiative
|
FDA
|
NIDCD
|
At the FDA, Dr. Weinberg is transducing murine keratinocytes with combinations of oncogenes found in human squamous cell carcinomas to determine if they generate transformation and tumors in laboratory environment conditions. Dr. Van Waes’ laboratory at NIDCD will study how these oncogene driven tumors in mice deregulate keratinocytes and host immune responses, as well as response to various standard, molecular and immune therapies.
|
|
Palliative Care: Maximizing Patient Preferences and Cost Savings
|
Research Initiative
|
AHRQ
|
CC
|
The goal of the study is to provide rational, patient-defined, evidence-based recommendations to inform the redesign of the Medicare hospice benefit, transitioning policy from the current hospice benefit to a more patient-centered palliative care model.
|
|
Partners in Information Access for the Public Health Workforce
|
Resource Development
|
AHRQ, CDC, HRSA, OS
|
NLM
|
Partners in Information Access for the Public Health Workforce is a collaboration of U.S. government agencies, public health organizations, and health sciences libraries which provides timely, convenient access to selected public health resources on the Internet.
|